The Transmissible Spongiform Encephalopathies (TSEs) or “prion” diseases are a group of fatal neurodegenerative diseases the aetiology of which is not fully understood. These diseases are characterised by a number of pathological changes in the central nervous system (CNS) including; vacuolation of the neuropil, gliosis and deposition of PrPSc; the abnormal form of the host glycoprotein PrP. Although the major pathology in these diseases is associated with the CNS the immune system is central to the pathogenesis of many natural and experimental TSEs including natural scrapie in sheep, chronic wasting disease in free ranging and captive deer and variant CJD (vCJD) in humans. Unlike many infectious diseases where deficiencies in immune function are opportunistic for the invading pathogen a competent immune system is required for efficient TSE infection via peripheral routes. As infection of the lymphoid tissues in many TSEs can occur many months before the detection of infectivity in the CNS, the determination of those cells in the lymphoid system has been the focus of much research and a number of studies now point towards the importance of the follicular dendritic cell (FDC), a long-lived radio resistant cell, in TSE pathogenesis. The involvement of FDCs in peripheral TSE pathogenesis relates to the inability of ionising radiation to influence pathogenesis, the association of PrP protein with FDCs in both uninfected and infected lymphoid tissues, and the demonstration that TSE pathogenesis is severely impaired in mice devoid of these cells. The aims of this thesis were to further understand the role of FDCs in the pathogenesis of a range of mouse-adapted experimental TSE strains and to determine if peripherally acquired TSE infections are influenced by host age or by stimulation of the immune system. Using chimaeric mouse models where a mismatch in the expression of PrP protein between FDCs and lymphoid/myeloid cells was produced, further evidence for a critical role for in the pathogenesis of the ME7 TSE strain was produced. Although these findings produced strong evidence that FDCs were important for the ME7 strain the possibility that different TSE strains may target different cell types in the peripheral lymphoid system was explored using a range of mice with specific immunological defects. Infection of these mice with several experimental TSE strains showed that the presence of mature FDCs was also important for the pathogenesis of the strains tested. Clinical cases of vCJD have been confined almost exclusively to young adults, although the reasons behind this apparent age-related susceptibility are not fully understood. The capacity of the immune system to mediate immune responses to pathogens declines with age as a result of impaired lymphocyte and FDC function. As FDCs are critically involved in the pathogenesis of many TSEs, including vCJD, it was hypothesised that an aging immune system may impair disease pathogenesis. Peripheral infection of senescent mice failed to produce clinical disease during lifespan, although evidence of disease transmission, was detected in a proportion of aged mice. These findings demonstrate that this inefficient disease transmission, as a consequence of age, may lead to considerable levels of sub-clinical disease within the population. Finally the influence of immune system stimulation, by the generation of a humoral immune response, on peripheral TSE pathogenesis was investigated. These findings demonstrated that immunisation can influence pathogenesis, but only during the early stages of infection prior to spread to the CNS. These data imply that modulation of the immune system does not alter TSE pathogenesis once disease has been initiated in the CNS. Finally, these studies have found some preliminary evidence that TSE infection may induce FDC activation suggesting that TSE infection may influence the immune response. Together, these data show that a functional immune system and specifically, the presence of mature FDCs, are central to the pathogenesis of peripherally acquired TSE infections.

<p>Calcium (Ca2+) is a known important second messenger. Calcium/Calmodulin (CaM) dependent protein kinase kinase 2 (CaMKK2) is a crucial kinase in the calcium signaling cascade. Activated by Ca2+/CaM, CaMKK2 can phosphorylate other CaM kinases and AMP-activated protein kinase (AMPK) to regulate cell differentiation, energy balance, metabolism and inflammation. Outside of the brain, CaMKK2 can only be detected in hematopoietic stem cells and progenitors, and in the subsets of mature myeloid cells. CaMKK2 has been noted to facilitate tumor cell proliferation in prostate cancer, breast cancer, and hepatic cancer. However, whethter CaMKK2 impacts the tumor microenvironment especially in hematopoietic malignancies remains unknown. Due to the relevance of myeloid cells in tumor growth, we hypothesized that CaMKK2 has a critical role in the tumor microenvironment, and tested this hyopothesis in murine models of hematological and solid cancer malignancies. </p><p>We found that CaMKK2 ablation in the host suppressed the growth of E.G7 murine lymphoma, Vk*Myc myeloma and E0771 mammary cancer. The selective ablation of CaMKK2 in myeloid cells was sufficient to restrain tumor growth, of which could be reversed by CD8 cell depletion. In the lymphoma microenvironment, ablating CaMKK2 generated less myeloid-derived suppressor cells (MDSCs) in vitro and in vivo. Mechanistically, CaMKK2 deficient dendritic cells showed higher Major Histocompatibility Class II (MHC II) and costimulatory factor expression, higher chemokine and IL-12 secretion when stimulated by LPS, and have higher potent in stimulating T-cell activation. AMPK, an anti-inflammatory kinase, was found as the relevant downstream target of CaMKK2 in dendritic cells. Treatment with CaMKK2 selective inhibitor STO-609 efficiently suppressed E.G7 and E0771 tumor growth, and reshaped the tumor microenvironment by attracting more immunogenic myeloid cells and infiltrated T cells.</p><p>In conclusion, we demonstrate that CaMKK2 expressed in myeloid cells is an important checkpoint in tumor microenvironment. Ablating CaMKK2 suppresses lymphoma growth by promoting myeloid cells development thereby decreasing MDSCs while enhancing the anti-tumor immune response. CaMKK2 inhibition is an innovative strategy for cancer therapy through reprogramming the tumor microenvironment.</p> / Dissertation

The primary aim of this thesis is to explore the immunostimulatory properties of a family of layered, crystalline, inorganic materials known as layered double hydroxides (LDHs). <strong>Chapter One</strong> provides an introduction to relevant aspects of the immune system, and the context for investigating the immunostimulatory properties of inorganic materials in terms of vaccine/adjuvant formulations. The possible mechanisms of action of commercial adjuvant materials are also reviewed, and the structure, synthesis methods and applications of LDHs are discussed. <strong>Chapter Two</strong> details the controlled synthesis and characterisation of LDHs in specific particle sizes. A series of MgAl-CO3 LDHs with precisely controlled particle sizes ranging from 20 to 10000 nm were successfully synthesised, then the techniques used were extended to other compositions to create a panel of LDHs for use in subsequent Chapters. In <strong>Chapter Three</strong>, the responses of monocyte-derived dendritic cells (Mo-DC) to the LDH particle sizes discussed in Chapter Two are assessed in terms of viability, surface molecule expression, and cytokine secretion. A statistical modelling approach using the physicochemical properties of the LDHs as explanatory variables for immune responses was employed to evaluate the validity of the model formulated in the previous work, and to establish if particle size could be used to improve its predictive ability. It was found that strong relationships between LDH particle size and certain Mo-DC responses exist, and that these responses could be predicted with a high degree of accuracy. <strong>Chapter Four</strong> is concerned with the investigation of T cell responses to LDH-stimulated allogeneic Mo-DC. Various methods were used for assessing T cell division and proliferation, and a protocol for intracellular cytokine staining was developed to probe T cell polarisation. Five LDHs, which have elicited potentially interesting T cell responses in previous work, were selected for investigation. However, using the assays described, no discernible improvement in proliferation or polarisation was observed with any of the LDHs tested. <strong>Chapter Five</strong> presents an initial exploration of the interactions between LDH particles and cells. Experiments have shown that LDH particles both adhere to and are internalised by Mo-DC. Variations in the extent of internalisation with both particle size and composition were highlighted by confocal microscopy studies. Through investigations into interactions between LDH particles and the plasma membrane using protease enzymes, it was revealed that adhesion of LDH particles is partly protein-dependent. Further studies have also demonstrated a pH-dependent element to particle association with Mo-DC. Details of the experimental procedures employed are included in <strong>Chapter Six</strong>. Supplementary information referred to in the main thesis may be found in the <strong>Appendices</strong>.

As células dendriticas (DC) da lamina própria constituem um grupo heterogêneo de células essenciais na homeostase do intestino. Nos últimos anos, estudos vem mostrando participação do complexo mTORC2 na regulação de células da imunidade inata. Desta forma, usando animais deficientes em mTORC2 nas DCs nos investigamos o papel deste complexo sob a funcoes das DCs num modelo de colite ulcerativa. Observamos que a ausência de mTORC2 nas DCs diminui a inflamação intestinal e prejudica a migração dessas células para os linfonodos. Consequentemente, estes animais também apresentam redução no numero de linfócitos Th17, Treg e T CD8&#43IFNg&#43. Estes resultados parecem ser independentes da composição da microbiota intestinal. In vitro, células dendriticas derivadas da medula ossea (BMDCs) deficientes em mTORC2 não mostraram deficiência na regulação positiva de CD80 e MHC-II quando estimuladas, mas mostraram menor produção de TNF-a e IL-6. Estas células também apresentaram menor capacidade na diferenciação de Th17. Nossos resultados indicam que mTORC2 participa na regulação das funções das DCs, especialmente na migração e produção de citocinas pos estímulos lnflamatorios. / Dendritic cells from lamina propria encompass a heterogeneous group of cells which play a key role in intestinal homeostasis. In the past few years, it has been shown the participation of mTORC2 in regulating innate immune cells. In our study, we used mTORC- deficient DCs to investigate the role of this complex in DCs functions in ulcerative colitis model. Absence of mTORC2 in DCs reduces the intestinal inflammation, impairs DCs migration which in turn decreases the number of Th17, Tregs and CD8&#43IFNg&#43 T cells. These results seem to be independent of gut microbiota composition. Our in vitro results showed that bone marrow-derived DCs (BMDCs) deficient in mTORC2 can upregulate CD80 and MHC-II after stimulus but present decreased production of TNF-a and IL-6. Those cells also showed deficiency in Th17 differentiation. Our results suggest that mTORC2 play pivotal role in DCs functions highlighting migration and cytokine production.

La constante augmentation des allergies en début de vie suggère une déficience de régulation immunitaire au cours de cette période. La tolérance orale est un mécanisme clé de régulation au niveau de l’intestin pour le maintien de l’homéostasie immunitaire. L’objectif de ma thèse a été de déterminer dans un modèle murin les mécanismes à l’origine de la tolérance orale en début de vie afin de mieux prévenir le développement d’allergies. L’induction de tolérance orale en début de vie n’est efficace qu’à partir de la 3ème semaine de vie. Le défaut de tolérance orale observé au cours des 2 premières semaines de vie est la conséquence d’un défaut de capture de l’antigène et d’expression de la RALDH (enzyme de conversion du rétinol en acide rétinoïque) par les cellules dendritiques CD103+ mésentériques, résultant en une ignorance de l’antigène. Les taux de rétinol sanguins en période néonatale sont très bas, et un enrichissement du lait maternel en vitamine A permet de corriger cette déficience néonatale ainsi que le défaut de présentation antigénique des cellules dendritiques CD103+. Cet enrichissement permet également de prévenir l’apparition de l’allergie dès les premiers jours de vie. De manière surprenante, alors que chez la souris adulte, la tolérance orale dépend de la génération de lymphocytes T régulateurs, la tolérance orale observée chez les souriceaux âgés de 3 semaines et chez les nouveau-nés ayant reçu de la vitamine A, dépend de la génération de lymphocytes Th1. / Increased prevalence of allergies in early life suggests a deficiency of immune regulation during this period. Oral tolerance is a key immuno-regulatory mechanism in the gut for immune homeostasis. The principal objective of my thesis was to determine in a murine model the mechanisms at the origin of oral tolerance in early life to better prevent allergy development. We found that induction of oral tolerance in early life is effective only from the 3rd week of life. The defect of oral tolerance observed during the first 2 weeks of life is the consequence of a defect in antigen capture and RALDH expression (enzyme which converts retinol in retinoic acid) by mesenteric CD103+ dendritic cells. Serum levels of retinol in neonatal period are very low, and an enrichment of the maternal milk with vitamin A allows to correct this neonatal deficiency as well as the defect of antigen presentation by the CD103+ dendritic cells. This enrichment also allows allergy prevention from the first days of life. To our surprise, while in adult mice, oral tolerance depends on the generation of regulatory T lymphocytes, oral tolerance observed in the 3 week-old mice and in the newborn which received vitamin A, depends on the generation of Th1 lymphocytes. These results demonstrate that vitamin A levels in early life are directly correlated with Th1 differentiation induced by oral administration of allergen, necessary for allergy prevention. This knowledge should now be taken into account for the implementation of allergy prevention strategies, more specific and better adapted to the neonatal period, such as a supplementation with vitamin A.

A descoberta de novos alvos terapêuticos capazes de reverter o efeito tumoral imunossupressor sobre as células dendríticas (DCs) é de grande relevância clínica. Identificamos que monócitos de pacientes com leucemia linfóide crônica (LLC) têm alterações na sinalização de STAT6 induzida por IL-4 que previne a maturação fenotípico-funcional das DCs. Embora os monócitos dos pacientes apresentem alta expressão de IL-4R, a atividade de STAT6 está inibida devido aos elevados níveis de SOCS5. IL-10 reproduz esta desregulação de STAT6/SOCS5 nos monócitos de doadores saudáveis, causando diferenciação defeituosa das DCs. Isso indica que SOCS5 está envolvida nas alterações das DCs de pacientes. Ainda, encontramos que a inibição de STAT3 com pirimetamina, um composto em ensaio clínico para LLC, não afeta a maturação das DCs, diferentemente da inibição de STAT5 por JQ1. Isso mostra que STAT5 é importante para a maturação das DCs, e sugere que a JQ1, mas não a pirimetamina, pode causar imunossupressão. Já SOCS5 pode ser um novo potencial alvo para terapia do câncer. / Discovery of new targets to reverse tumor immunosuppression on dendritic cells (DCs) hold great therapeutic promise. Here, we identify that monocytes from chronic lymphocytic leukemia (CLL) patients have alteration in IL-4-induced STAT6 signaling that prevents DCs phenotypic and functional maturation. Although patients monocytes display high IL-4R expression, STAT6 activity is inhibited because of elevated SOCS5 levels. IL-10-treatment of healthy donors monocytes reproduces this altered mechanism (STAT6/SOCS5) and leads to a defective DC differentiation. These findings indicate that a high SOCS5 level is involved on CLL-DCs impaired function. Moreover, we find that pharmacologic inhibition of STAT3 by pyrimethamine, a clinical trial compound for CLL, does not affect LPS-induced DCs maturation while STAT5 inhibition by JQ1 prevents it. Our findings show that STAT5 is important for DCs maturation, and suggest that JQ1, but not pyrimetamine, can cause immunosuppression. Additionally, SOCS5 emerges as a new potential target for cancer treatment.

Les cellules dendritiques (DCs) possèdent des rôles clés dans la modulation de la réponse inflammatoire. Leur implication dans la réponse inflammatoire post-ischémie/reperfusion semble claire. Cependant, leurs rôles spécifiques restent encore à élucider. Nous avons émis l’hypothèse selon laquelle la modulation de la réponse des cellules dendritiques suite à la séquence d’ischémie/reperfusion pourrait diminuer les lésions du greffon cardiaque. L’objectif de ce travail a donc consisté en l’exploration et l’identification d’un mécanisme immunomodulateur dans la DC. Un modèle cellulaire d’hypoxie/réoxygénation (H/R) et un modèle de co-culture DCs / cardiomyocytes ont été utilisés. / Dendritic cells (DCs) play key roles during the inflammatory process. Although their involvement in ischemia/reperfusion (I/R)-related inflammation is known, their specific role in such a context remain to be elucidated.We hypothesized that the modulation of DC phenotype during I/R might decrease cardiac graft injuries. In this study, we aimed to explore and identify an immunomodulatory mechanism in DCs. An in vitro model of hypoxia/reoxygenation (H/R) and a co-culture model were used. Our results highlight that the purinergic receptor P2Y11 (P2Y11R) exhibits an immunosuppressive role in DCs. This effect was lost when cells were subjected to a H/R insult, due to P2Y11R downregulation during hypoxia.

Células dendríticas (DCs) são as responsáveis por orquestrar a resposta imunológica adaptativa através da estimulação de células T. Na imunoterapia do câncer, as DCs são um dos principais alvos de estimulação. Entretanto a maturação anormal destas pode interferir no resultado final da resposta imune. Neste estudo, analisaram-se os efeitos causados pelo fator de crescimento endotelial vascular (VEGF) na maturação de DCs. Nas DCs maturadas em presença de VEGF, utilizando-se citoquímica, constatou-se alterações morfológicas, como número reduzido de dendritos e citoplasma basofílico; a análise de expressão gênica global por microarranjos de DNA mostrou grande variação da expressão de genes relacionados com adesão celular e citoesqueleto. Na avaliação funcional verificou-se redução da capacidade das DCs de ativar linfócitos. Juntos esses resultados sugerem que células expostas ao VEGF seriam menos especializadas. A compreensão do impacto do VEGF em mecanismos de maturação celular contribui para o entendimento da supressão imunológica nos tumores que secretam VEGF. / Dendritic cells (DCs) are in charge of orchestrating the adaptive immune response through T cells activation. DCs are the main target in cancer cell immunotherapy. However, DCs inadequate maturation interferes in the outcome of the immune response. In this study, were analyzed the effects of vascular endothelial growth factor (VEGF) on DCs maturation. DCs matured in the presence of VEGF, showed morphologic alterations such as reduced number of dendrites and basophilic cytoplasm by cytochemistry. Global gene expression assessed by DNA microarrays demonstrated broad variation in the expression of cell adhesion and cytoskeleton regulation-related genes. Functional studies detected the reduced capacity of VEGF-exposed DCs in the activation of lymphocytes. All together these results suggest that cells exposed to VEGF are less differentiated, a possible mechanism involved in the immune suppression caused by VEGF secreting tumors.

A leishmaniose visceral (LV) é uma doença crônica e potencialmente fatal causada, no Brasil, pelo protozoário Leishmania infantum. A resistência à LV é relacionada ao desenvolvimento de uma resposta imune celular eficiente. Para isso, células dendríticas (DCs) reconhecem produtos antigênicos do parasito, através dos Toll-like Receptors (TLRs), e, após ativação, produzem fatores, que irão orquestrar o recrutamento celular e desenvolvimento da resposta imune protetora. Dentre os vários TLRs, tem sido demonstrado que o TLR9 está relacionado com a resistência à infecção em modelo de leishmaniose cutânea. No presente estudo, nosso objetivo foi determinar o papel do TLR9 durante a infecção por L. infantum. Nossos resultados demonstram que a expressão de TLR9 é modulada positivamente durante a infecção in vivo e in vitro pela L. infantum. O TLR9 é essencial para o controle da infecção contra L. infantum, uma vez que camundongos TLR9-/- são mais susceptíveis à infecção, apresentando maior número de parasitos no baço e fígado na 4ª e 6ª semana pós-infecção. A fenotipagem de leucócitos presente no baço demonstrou que camundongos TLR9-/- possuem menor número de neutrófilos. De maneira semelhante, a análise imuno-histoquímica mostrou uma reduzida marcação de células 7/4+ (específica para neutrófilos) no fígado de animais TLR9-/-. A falha na migração de neutrófilos observada em animais TLR9-/- não está associada a uma incapacidade de ativação dos polimorfonucleares, mas sim a deficiências na produção de fatores quimiotáticos, como CXCL1 (KC) e CXCL2 (MIP-2) nos órgãos-alvo. Investigando o mecanismo de ação, as células dendríticas oriundas de animais TLR9-/- falham em seu processo de ativação frente à infecção in vitro e in vivo com L. infantum, apresentando um fenótipo semi-maduro, com redução de expressão de MHC-II e moléculas coestimuladoras. Interessante que essas células apresentaram deficiência na produção de mediadores quimiotáticos de neutrófilos como KC e MIP-2, e consequentemente, induzindo o menor recrutamento de neutrófilos in vitro. Em conjunto, nossos resultados demonstram que o TLR9 é essencial para o controle da infecção por L. infantum, através de um mecanismo dependente do recrutamento de neutrófilos para o sítio inflamatório mediado pela ativação apropriada de fatores quimiotáticos de neutrófilos pelas DCs. / Visceral leishmaniasis (VL) is a chronic and potentially fatal disease caused by protozoan Leishmania infantum, in Brazil. The resistance against VL is related to the development of cellular immune response. During infection, the dendritic cells (DCs) recognize antigenic products through Toll-like Receptors (TLRs) and then orchestrate the cellular recruitment and immune response development. Among several TLRs, it has been showed that TLR9 is related to resistance to cutaneous leishmaniasis. In the present study, our aim was to determinate the role of TLR9 during L. infantum infection. Our results demonstrated that TLR9 is up regulated during in vitro and in vivo L. infantum infection. TLR9 is critical for protective immunity against L. infantum, since TLR9-/- mice infected were more susceptible to infection, displaying high amounts of parasites in spleen and liver, at 4th and 6th weeks post-infection. Phenotyping the leukocytes into the spleen, TLR9-/- mice presented reduced neutrophils when compared to WT. Likewise, imunohistochemistry analyses showed the reduced of 7/4+ cells (specific to neutrophils) staining into the TLR-9-/- liver. The failure of neutrophil migration is not associated to their stage of activation impaired, but due the reduced levels of CXCL1 (KC) and CXCL2 (MIP-2) (neutrophil chemoatracttant) produced into into the spleen cells culture from infected TLR9-/-. Furthermore, DCs from TLR9-/- presented a semi-mature stage during in vitro and in vivo L. infantum infection, showing reduced expression of MHC-II and co-stimulatory molecule. Interestingly, the ability of DC to produce the neutrophil chemotact mediators (KC and MIP-2) was completely reduced by that derived from TLR9-/- mice, affecting neutrophil migration into Boyden chamber. Altogether, we demonstrated that TLR9 presents a critical role in the protective response against L.infantu through the mechanism dependent of crosstalk between neutrophil recruitment and DC activation.

The 21st century has been called the age of genomic medicine, yet gene therapy for medicinal use remains a theory. One reason that there are no safe and effective treatments for human disease is the lack of a vehicle capable of delivering genetic material to a specific target. In nature we observe gene pathology by viral vectors, which deliver their own genetic material to specific host cells efficient at spreading the viral blueprint throughout the organism. The aim of my research into gene therapy has been to develop a synthetic vector with the delivery capability of viral vectors found in nature. This includes the ability to protect genetic cargo from modification and degradation in vivo, target to a desired cell type within a specific tissue, facilitating absorption into the cell, and delivery to the nucleus, where expression of genetic material occurs. The goal of this thesis project was to synthesize a novel vector which would selectively target the dendritic cell SIGN receptor, mirroring the method of pathogens such as HIV, which target this receptor and subsequently the immune system, resulting in chronic infection. The vector we designed contains two major components, the high mannose N-glycan Man9GlcNAc2Asn, and a peptide composed of nine amino acids: four lysine spacing residues, four lysines derivatized with acridine on the epsilon amine of their side chains, and a cysteine for conjugation to the glycan. This compound, the Man9-AcrLys Glycopeptide, was engineered to intercalate into plasmid DNA via the acridine functional groups and to bind the DC-SIGN receptor through the glycan's mannose residues. The vehicle was tested in vitro in CHO cells bearing a recombinant DC-SIGN receptor in the context of luciferase reporter gene delivery. We found that under equal treatment conditions, DC-SIGN (+) CHO cells expressed more luciferase and were 100-fold more luminescent than control DC-SIGN (-) CHO cells. My delivery method was further analyzed in a cell-sorting FACS experiment. I covalently labeled pGL3 reporter plasmid with a fluorophore, and transfected the CHO cells under typical transfection conditions. The experimental results confirmed preferential DC-SIGN mediated gene delivery.